Rationale for a Neisseria gonorrhoeae Susceptible Only Interpretive Breakpoint for Azithromycin

BACKGROUND: Azithromycin (AZI) is recommended with Ceftriaxone (CRO) for treatment of uncomplicated gonococcal urethritis and cervicitis in the United States (US) and an AZI susceptibility breakpoint is needed. Neither the FDA (Food and Drug Administration) nor the CLSI (Clinical and Laboratory Stan...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Kersh, Ellen N., Allen, Vanessa, Ransom, Eric, Schmerer, Matthew, St. Cyr, Sancta, Workowski, Kim, Weinstock, Hillard, Patel, Jean, Ferraro, Mary Jane
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6785360/
https://ncbi.nlm.nih.gov/pubmed/30963175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz292
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars